Logo Image
News|Articles|December 31, 2025

​​Sleep in 2025: Year in Review

Fact checked by: Tim Smith

From FDA decisions to late-phase trial readouts and updated practice guidelines, 2025 delivered clinically actionable insights across sleep conditions.

The past year brought several important updates in sleep medicine, including new US Food & Drug Administration (FDA) approvals, trial results, and guideline changes with direct implications for clinical practice. These updates affected the management of obstructive sleep apnea (OSA), narcolepsy, restless legs syndrome (RLS), and idiopathic hypersomnia (IH), giving clinicians additional evidence-based treatment options.